Clinical trial

RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin…

NCT03044665 · Yonsei University, Other · Unknown status

Key facts

NCT number NCT03044665
Title RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)
Official title RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)
Lead sponsor Yonsei University, Other
Status Unknown status
Study type Interventional
Conditions Cardiovascular Diseases, Cerebrovascular Disease, Peripheral Atherosclerotic Disease
Intervention type Drug
Interventions Rosuvastatin, Rosuvastatin plus ezetimibe
Enrollment 3,780
Start date Mar 15, 2017
Primary completion Jan 15, 2022
Completion Feb 15, 2023
First posted Feb 7, 2017
Last update posted Jan 16, 2019
Countries South Korea

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies